Industry
NanoString Technologies to Accelerate Commercialization of Expression Profiling Products
NanoString Technologies will receive US$30 million equity financing, which will allow the company to accelerate commercialization of the nCounter analysis system for diagnostics and research. More...15 Jun 2009
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
In Other News
Ipsogen Expands Market Presence in the United States
PerkinElmer Enhances Mass Spectrometry Product Range and Expertise
Market Opportunities Appear for Improved Swine Flu Diagnostic Tests
Celera Licenses Genetic-Analysis Products for Diagnostic Development
Alpine Biomed Opens Vietnam Facility for Diagnostic Devices
Prometheus Enters Oncology Market via Agreement With Rosetta Genomics
Multiplex Mass Spectrometric Immunoassays Will Improve Cancer Diagnosis
Beckman Coulter Augments Genomic Services with Cogenics Acquisition
Independent Market Research Ranks Sysmex in Hematology Instruments
Noninvasive Prenatal Genetic Screening Tests Are Safer
Lab21 Expands Microbiology Offering With Acquisition of Biotec
Nanogen Expands Partnership with HandyLab for IVD Testing
Innovative Biosensors Develops Rapid Diagnostics System With Progentech
Millipore Acquires Technology for Developing Antibodies
Novel Technologies Drive European IVD Cancer Sector
Beckman To Buy Diagnostics Business from Olympus for $800 Million
Prediabetes Screening Test Completed Within One Hour
IVD Sector Not Affected by Current Economic Conditions
Noninvasive Prenatal Blood Test To Predict Genetic Disorders
Sequenom Acquires SensiGen and Expands Molecular Diagnostics Portfolio
XDx Develops Blood Tests To Identify Lupus Biomarkers
Abbott To Offer New Approach to Pathogen Detection
Molecular Diagnostics Emerging Rapidly for Routine Patient Care
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.